Filing Details

Accession Number:
0001140361-15-026264
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-01 16:27:53
Reporting Period:
2015-06-30
Filing Date:
2015-07-01
Accepted Time:
2015-07-01 16:27:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588365 Ezio Bonvini 9640 Medical Center Drive
Rockville MD 20850
Senior Vp, Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-30 6,497 $0.71 43,287 No 4 M Direct
Common Stock Disposition 2015-06-30 6,497 $38.07 36,790 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2015-06-30 6,497 $0.00 6,497 $0.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,921 2005-09-24 2016-03-23 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2015